Acro Biomedical (ACBM) Tax Provisions (2018 - 2025)

Acro Biomedical has reported Tax Provisions for 7 years, with the latest figure at -$21241.0 in Q4 2025.

• On a quarterly basis, Tax Provisions fell 139.15% year-over-year to -$21241.0 in Q4 2025; TTM through Dec 2025 was -$21241.0, a 139.15% decrease from a year earlier, with the FY2025 full-year figure at -$21241.0, down 139.15% from the prior year.
• Tax Provisions was -$21241.0 for Q4 2025 at Acro Biomedical, down from -$8882.0 in the prior quarter.
• The five-year high for Tax Provisions was -$8882.0 in Q4 2024, with the low at -$1.8 million in Q4 2023.
• Average Tax Provisions over 4 years is -$874064.2, with a median of -$818892.5 recorded in 2021.
• The sharpest annual moves came in 2024 and 2025: Tax Provisions surged 99.52% in 2024, then slumped 139.15% in 2025.
• Over 4 years, Tax Provisions stood at -$1.6 million in 2021, then retreated by 14.42% to -$1.8 million in 2023, then soared by 99.52% to -$8882.0 in 2024, then plunged by 139.15% to -$21241.0 in 2025.
• The last three Tax Provisions figures came in at -$21241.0 (Q4 2025), -$8882.0 (Q4 2024), and -$1.8 million (Q4 2023), per Business Quant data.